Richard Burr: “The Navy of continuing to mischaracterize a 2009 report by the National Academy of the Sciences' National Research…”

I am concerned Ms. Kotagal lacks impartiality to interpret the law.

Without Orrin, we wouldn't have a generic drug industry.

When is somebody going to share with the American people the destination we are trying to get to and how we are going to get to that destination?

The faster, more predictable, and more accountable the programs are, the more patients stand to benefit from lifesaving, innovative drugs and devices.